Antimetastatic and Antitumor Activities of Orally Administered NAX014 Compound in a Murine Model of HER2-Positive Breast Cancer

by Elisa Pierpaoli, Francesco Piacenza, Gaetano Fiorillo, Paolo Lombardi, Fiorenza Orlando, Carmela Salvatore, Cristina Geroni, Mauro Provinciali
Published 2021-03-01